Cargando…

Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer

The standard regimen of second-line chemotherapy for patients with unresectable gastric cancer has not been established. However, weekly paclitaxel (wPTX) has become the preferable second-line chemotherapy in Japan. Histone deacetylase (HDAC) inhibitors have been shown to have antiproliferative acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fushida, Sachio, Kaji, Masahide, Oyama, Katsunobu, Hirono, Yasuo, Nezuka, Hideaki, Takeda, Toshiya, Tsukada, Tomoya, Fujimoto, Daisuke, Ohyama, Shigekazu, Fujimura, Takashi, Ohta, Tetsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410891/ https://www.ncbi.nlm.nih.gov/pubmed/25960665 http://dx.doi.org/10.2147/OTT.S83114

Ejemplares similares

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial
por: Fushida, Sachio, et al.
Publicado: (2016)

A randomized controlled trial of postoperative intravenous acetaminophen plus thoracic epidural analgesia vs. thoracic epidural analgesia alone after gastrectomy for gastric cancer
por: Kinoshita, Jun, et al.
Publicado: (2018)

Arandomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease
por: Fushida, Sachio, et al.
Publicado: (2015)

Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin
por: Oyama, Katsunobu, et al.
Publicado: (2015)

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer
por: TSUKADA, TOMOYA, et al.
Publicado: (2013)

Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
por: Ohbatake, Yoshinao, et al.
Publicado: (2015)

Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy
por: Fushida, Sachio, et al.
Publicado: (2018)

Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line
por: HIROSE, ATSUSHI, et al.
Publicado: (2013)

The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer
por: TSUKADA, TOMOYA, et al.
Publicado: (2012)

Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma
por: Kanamoto, Ayako, et al.
Publicado: (2016)

Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis
por: Okazaki, Mitsuyoshi, et al.
Publicado: (2017)

The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance
por: Okazaki, Mitsuyoshi, et al.
Publicado: (2018)

Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line
por: Yagi, Yasumichi, et al.
Publicado: (2010)

Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer
por: Tsukada, Tomoya, et al.
Publicado: (2011)

Bone marrow derived “fibrocytes” contribute to tumor proliferation and fibrosis in gastric cancer
por: Terai, Shiro, et al.
Publicado: (2014)

Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study
por: Saito, Hiroto, et al.
Publicado: (2017)

Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast
por: Saito, Hiroto, et al.
Publicado: (2017)

Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway
por: SHINBO, TOSHIFUMI, et al.
Publicado: (2015)

Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells
por: NINOMIYA, ITASU, et al.
Publicado: (2014)

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody
por: Fushida, Sachio, et al.
Publicado: (2013)

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum
por: NINOMIYA, ITASU, et al.
Publicado: (2012)

Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation
por: MAWATARI, TOSHIKI, et al.
Publicado: (2015)

Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
por: Kinoshita, Jun, et al.
Publicado: (2014)

Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination
por: Yamaguchi, Takahisa, et al.
Publicado: (2015)

Thoracoscopic radical esophagectomy and laparoscopic transhiatal lymph node dissection for superficial esophageal cancer associated with lymph node metastases in the dorsal area of the thoracic aorta
por: Ninomiya, Itasu, et al.
Publicado: (2015)

Isolated adrenocorticotropic hormone deficiency development during chemotherapy for gastric cancer: a case report
por: Kinoshita, Jun, et al.
Publicado: (2014)

Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis
por: Okazaki, Mitsuyoshi, et al.
Publicado: (2019)

Extravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case report
por: NAKANUMA, SHINICHI, et al.
Publicado: (2015)

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil
por: Kurata, Toru, et al.
Publicado: (2018)

A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer
por: TAJIMA, HIDEHIRO, et al.
Publicado: (2013)

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME
por: Chevalier, Thomas, et al.
Publicado: (2021)

Duodenal ulcer penetration into the liver at the previous left hemihepatectomy site()
por: Hayashi, Hironori, et al.
Publicado: (2013)

A Pilot Study of Chemoradiotherapy With Weekly Docetaxel for Thoracic Esophageal Carcinoma With T4 and/or M1 Lymph Node Metastasis
por: Makino, Isamu, et al.
Publicado: (2011)

Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients
por: Comella, P, et al.
Publicado: (2004)

Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis
por: Fushida, S., et al.
Publicado: (2013)

Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
por: Kokubu, Hiraku, et al.
Publicado: (2023)

Multiple liver metastases of pancreatic solid pseudopapillary tumor treated with resection following chemotherapy and transcatheter arterial embolization: A case report
por: TAJIMA, HIDEHIRO, et al.
Publicado: (2015)

Treatment of capecitabine-induced hand-foot syndrome using a topical retinoid: A case report
por: INOKUCHI, MASAFUMI, et al.
Publicado: (2014)

Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
por: Chen, Shuling, et al.
Publicado: (2023)

Low-dose valproic acid with low-dose gemcitabine augments MHC class I-related chain A/B expression without inducing the release of soluble MHC class I-related chain A/B
por: Miyashita, Tomoharu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_148539496s1pngd3cj93f9189o